Industries de la santé
To help eradicate neglected tropical diseases, pharma must juggle ROI concerns and social responsibility
28 Février 2018
In a bid to rid the world of infectious diseases, pharmaceutical companies are continuously striving to align their financial considerations – specifically, maximizing their return on R&D investment (ROI) – with corporate social responsibility. Drug and vaccine developers can reach this compromise by partnering with public authorities and other entities in order to mitigate upfront... |Plus d'articles...
- Johnson & Johnson Medical Devices Companies Acquire Orthotaxy to Develop Next-Generation Robotic-Assisted Surgery Platform in Orthopaedics
- Alzheimer’s pipeline is no closer to FDA-approved breakthrough after drug failures in 2017
- CARMAT accélère l'internationalisation de l'étude PIVOT et obtient l'autorisation de réaliser des implantations au Danemark
- Le GKT831, candidat médicament le plus avancé de Genkyotex